Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $31.02 Analyst target: $55.82 Upside: 79.95%
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.